Next Article in Journal
Recent Discovery of Heterocyclic Alkaloids from Marine-Derived Aspergillus Species
Previous Article in Journal
Pre-Treatment with Laminarin Protects Hippocampal CA1 Pyramidal Neurons and Attenuates Reactive Gliosis Following Transient Forebrain Ischemia in Gerbils
Open AccessEditorial

Marine Drugs Acting as Autophagy Modulators

by Sergey A. Dyshlovoy 1,2,3,4,* and Friedemann Honecker 2,5,*
Laboratory of Pharmacology, A.V. Zhirmunsky National Scientific Center of Marine Biology, Far Eastern Branch, Russian Academy of Sciences, Vladivostok 690041, Russia
Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany
Department of Bioorganic Chemistry and Biotechnology, Laboratory of Biologically Active Compounds, School of Natural Sciences, Far Eastern Federal University, Vladivostok 690091, Russia
Martini-Klinik, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, 20251 Hamburg, Germany
Tumor and Breast Center ZeTuP St. Gallen, 9000 St. Gallen, Switzerland
Authors to whom correspondence should be addressed.
Mar. Drugs 2020, 18(1), 53;
Received: 18 December 2019 / Revised: 25 December 2019 / Accepted: 9 January 2020 / Published: 14 January 2020
(This article belongs to the Special Issue Marine Drugs Acting as Autophagy Modulators)
Note: In lieu of an abstract, this is an excerpt from the first page.

Autophagy (Ancient Greek αὐτόφαγος [autóphagos]—“self-devouring”) is defined as a regulated mechanism of the degradation of unnecessary or dysfunctional cellular components [...] View Full-Text
MDPI and ACS Style

Dyshlovoy, S.A.; Honecker, F. Marine Drugs Acting as Autophagy Modulators. Mar. Drugs 2020, 18, 53.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop